Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 55% ± 11% | |
lung | 17 studies | 39% ± 12% | |
intestine | 11 studies | 35% ± 14% | |
kidney | 7 studies | 40% ± 11% | |
lymph node | 6 studies | 47% ± 12% | |
bone marrow | 5 studies | 31% ± 15% | |
placenta | 4 studies | 42% ± 20% | |
eye | 4 studies | 31% ± 8% | |
uterus | 4 studies | 55% ± 11% | |
breast | 4 studies | 49% ± 7% | |
brain | 4 studies | 26% ± 4% | |
liver | 4 studies | 48% ± 16% | |
pancreas | 3 studies | 43% ± 14% | |
prostate | 3 studies | 33% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7425.68 | 1445 / 1445 | 100% | 80.38 | 183 / 183 |
ovary | 100% | 11976.73 | 180 / 180 | 100% | 143.28 | 430 / 430 |
pancreas | 100% | 8051.69 | 328 / 328 | 100% | 109.20 | 178 / 178 |
skin | 100% | 8944.77 | 1809 / 1809 | 100% | 144.94 | 472 / 472 |
prostate | 100% | 8514.64 | 245 / 245 | 100% | 139.93 | 501 / 502 |
uterus | 100% | 9621.85 | 170 / 170 | 100% | 119.35 | 458 / 459 |
thymus | 100% | 7243.44 | 652 / 653 | 100% | 138.53 | 604 / 605 |
intestine | 100% | 8266.27 | 966 / 966 | 100% | 129.63 | 525 / 527 |
kidney | 100% | 6477.30 | 89 / 89 | 99% | 85.91 | 896 / 901 |
lung | 100% | 6674.51 | 577 / 578 | 99% | 91.58 | 1149 / 1155 |
stomach | 100% | 7369.53 | 359 / 359 | 99% | 113.99 | 284 / 286 |
breast | 100% | 8992.00 | 459 / 459 | 99% | 103.65 | 1110 / 1118 |
brain | 99% | 3555.18 | 2621 / 2642 | 100% | 112.05 | 705 / 705 |
liver | 100% | 3383.07 | 225 / 226 | 100% | 89.55 | 404 / 406 |
bladder | 100% | 8446.57 | 21 / 21 | 99% | 114.57 | 498 / 504 |
adrenal gland | 100% | 6889.16 | 258 / 258 | 98% | 89.79 | 226 / 230 |
adipose | 100% | 8570.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 250.85 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 211.02 | 29 / 29 |
muscle | 100% | 13589.42 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8115.95 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 113.58 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 77.13 | 1 / 1 |
blood vessel | 100% | 8708.57 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 6982.27 | 917 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 5465.15 | 849 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001732 | Biological process | formation of cytoplasmic translation initiation complex |
GO_0075525 | Biological process | viral translational termination-reinitiation |
GO_0006413 | Biological process | translational initiation |
GO_0033290 | Cellular component | eukaryotic 48S preinitiation complex |
GO_0005829 | Cellular component | cytosol |
GO_0016282 | Cellular component | eukaryotic 43S preinitiation complex |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005852 | Cellular component | eukaryotic translation initiation factor 3 complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | EIF3G |
Protein name | Eukaryotic translation initiation factor 3 subunit G Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) (eIF-3-delta) (eIF3 p42) (eIF3 p44) |
Synonyms | EIF3S4 |
Description | FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis . The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation . The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression . This subunit can bind 18S rRNA. .; FUNCTION: (Microbial infection) In case of FCV infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of VP2 . . FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. This subunit can bind 18S rRNA. . FUNCTION: RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression. This subunit can bind 18S rRNA. . |
Accessions | K7EL20 ENST00000587993.5 ENST00000593095.5 ENST00000593066.5 A8K5K5 K7ERL8 K7EL60 ENST00000589454.5 ENST00000253108.9 ENST00000593054.5 ENST00000587146.5 K7EP16 K7ENA8 K7ER90 K7ENH0 ENST00000588709.5 O75821 Q6IAM0 |